Free Trial
→ Ex-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000” (From Colonial Metals) (Ad) Free MBRX Stock Alerts

Moleculin Biotech (MBRX) SEC Filings & 10K Form

Moleculin Biotech logo
$1.28 -0.12 (-8.57%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$1.29 +0.01 (+0.70%)
As of 02/21/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Moleculin Biotech SEC Filings

Export to Excel
DateFilerForm TypeView
02/14/2025
4:51 PM		ARMISTICE CAPITAL, LLC (Filed by)
Moleculin Biotech (Subject)
Form SCHEDULE 13G/A
02/13/2025
3:17 PM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2025
8:25 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2025
8:25 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2025
7:31 AM		Moleculin Biotech (Filer)
Form S-1/A
02/10/2025
7:32 AM		Moleculin Biotech (Filer)
Form S-1/A
02/10/2025
7:33 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2025
8:18 AM		Moleculin Biotech (Filer)
Form S-1/A
01/27/2025
11:08 AM		Moleculin Biotech (Filer)
Form 8-K/A
01/27/2025
8:16 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/27/2025
7:30 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
7:30 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
7:30 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2024
7:15 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2024
4:02 PM		Moleculin Biotech (Filer)
Form S-1
Registration statement under Securities Act of 1933  
12/11/2024
7:15 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2024
11:15 PM		Moleculin Biotech (Filer)
Form EFFECT
12/03/2024
4:20 PM		Moleculin Biotech (Filer)
Form POS AM
11/18/2024
7:20 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
7:20 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
7:35 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
7:15 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2024
6:30 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
4:09 PM		Moleculin Biotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
7:00 PM		KLEMP WALTER V (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
7:00 PM		Foster Jonathan P. (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
7:03 PM		Moleculin Biotech (Issuer)
PICKER DONALD H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
7:03 PM		CANNON MICHAEL D (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
7:03 PM		George Robert E. (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
7:04 PM		Climaco John M (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
7:05 PM		Cermak Elizabeth (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
7:06 PM		Moleculin Biotech (Issuer)
Yan Joy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
4:27 PM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2024
3:43 PM		Moleculin Biotech (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
10/25/2024
3:16 PM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
7:40 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/07/2024
7:30 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2024
7:00 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2024
7:31 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2024
7:15 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
7:15 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This Crypto Is Set to Explode in February (Ad)

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

YES, I WANT THE #1 CRYPTO NOW
09/03/2024
4:15 PM		Moleculin Biotech (Filer)
Form PRE 14A
08/19/2024
3:10 PM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2024
9:06 AM		Moleculin Biotech (Filer)
Form 424B3
08/16/2024
3:54 PM		Moleculin Biotech (Filer)
Form 424B4
08/15/2024
11:15 PM		Moleculin Biotech (Filer)
Form EFFECT
08/15/2024
10:21 AM		Moleculin Biotech (Filer)
Form S-1/A
08/14/2024
8:57 PM		Moleculin Biotech (Filer)
Form S-1/A
08/14/2024
7:05 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2024
8:05 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2024
7:30 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2024
7:35 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2024
6:00 AM		Moleculin Biotech (Filer)
Form S-1/A
07/22/2024
4:31 PM		Moleculin Biotech (Filer)
Form S-1
Registration statement under Securities Act of 1933  
07/10/2024
7:30 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/05/2024
4:01 PM		KLEMP WALTER V (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
11:15 PM		Moleculin Biotech (Filer)
Form EFFECT
06/25/2024
5:00 PM		KLEMP WALTER V (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
5:01 PM		Foster Jonathan P. (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
5:02 PM		Moleculin Biotech (Issuer)
PICKER DONALD H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
4:00 PM		KLEMP WALTER V (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
4:01 PM		Foster Jonathan P. (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
4:01 PM		Moleculin Biotech (Issuer)
PICKER DONALD H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
7:00 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
4:05 PM		Moleculin Biotech (Filer)
Form S-3
Registration statement under Securities Act of 1933  
05/16/2024
7:32 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
7:38 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
3:16 PM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2024
6:30 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
7:30 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
7:31 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
7:55 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2024
8:00 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2024
4:15 PM		Moleculin Biotech (Filer)
Form 10-K/A
04/25/2024
7:23 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/18/2024
7:30 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2024
7:30 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2024
7:30 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2024
4:14 PM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2024
8:05 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2024
2:03 PM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2024
6:30 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2024
6:30 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2024
3:31 PM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/29/2024
7:30 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/22/2024
8:30 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:MBRX) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners
[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIED
Robert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...
NewMarket Health Publishing, LLC. | Sponsored
Elon’s “New Gold”
MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...
True Market Insiders | Sponsored
Buy NVDA Now?
After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...
Chaikin Analytics | Sponsored
This Crypto Is Set to Explode in February
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...
Crypto 101 Media | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
Market down? Do this now.
During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...
Colonial Metals | Sponsored
Is Starlink Set For The Largest IPO In History?
He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...
Paradigm Press | Sponsored
Critical ‘Buy Now’ Alert on My Favorite Stock!
My absolute favorite stock just hit a critical "buy now" trigger price.
Behind the Markets | Sponsored